Clinical Trial Update: Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer [NA]

View source ↗

Summary

A clinical trial evaluating circulating tumor DNA guided treatment monitoring in advanced non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Zealand University Hospital | Conditions: Non-small Cell Lung Cancer Metastatic | NA | Status: RECRUITING